Indianapolis-based FAST BioMedical has added Jim Dillon to its board of directors. Dillon serves as chief executive officer of  Massachusetts-based Reprieve Cardiovascular. Dillon is also a former St. Jude Medical and Abiomed executive. 

He has more than 30 years of experience in healthcare. While at St. Jude, Dillon oversaw the Medical’s America’s product portfolio including Structural Heart and Heart Failure.  At Abiomed, Dillon led US core business growth with a strategic focus on native heart recovery.

 

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}